TY - JOUR
KW - 12-Item Short Form Health Survey
KW - 3211:Affective Disorders
KW - 3300:Health & Mental Health Treatment & Prevention
KW - 36-Item Short Form Health Survey
KW - Adulthood (18 yrs & older)
KW - Aged (65 yrs & older)
KW - Antidepressant Drugs
KW - antidepressant medication
KW - article
KW - Beck Depression Inventory-II
KW - Cognitive Behavior Therapy
KW - cognitive behavioral therapy
KW - cost effectiveness
KW - Costs and Cost Analysis
KW - Drug Therapy
KW - Empirical Study
KW - European Quality of Life-5D-3L
KW - Female
KW - Followup Study
KW - Human
KW - Interview
KW - Male
KW - Middle Age (40-64 yrs)
KW - pharmacotherapy
KW - primary care
KW - Primary Health Care
KW - Quantitative Study
KW - Revised Clinical Interview Schedule
KW - Thirties (30-39 yrs)
KW - Treatment Outcome/Clinical Trial
KW - treatment resistant depression
KW - United Kingdom
KW - Young Adulthood (18-29 yrs)
AU - Sandra Hollinghurst
AU - Fran E. Carroll
AU - Anna Abel
AU - John Campbell
AU - Anne Garland
AU - Bill Jerrom
AU - David Kessler
AU - Willem Kuyken
AU - Jill Morrison
AU - Nicola Ridgway
AU - Laura Thomas
AU - Katrina Turner
AU - Chris Williams
AU - Tim J. Peters
AU - Nicola Wiles
AU - Glyn Lewis
A1 - 
BT - The British Journal of Psychiatry
C5 - Financing & Sustainability
CP - 1
IS - 1
JF - The British Journal of Psychiatry
PB - Royal College of Psychiatrists
PY - 2014
SN - 0007-1250, 0007-1250
SP - 69
EP - 76
EP - 
T1 - Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
T2 - The British Journal of Psychiatry
TI - Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
U1 - Financing & Sustainability
VL - 204
VO - 0007-1250, 0007-1250
Y1 - 2014
ER -